Biopharma Equities

Comanche Biopharma Secures $75 Million in Series B Funding for Preeclampsia Treatment Development Jan 17, 2024

Immix Biopharma Reports Unprecedented 100% ORR for CAR-T NXC-201 in AL Amyloidosis at ASH 2023 Dec 12, 2023